FH expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.333400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.778000E-01
Normal-vs-Stage2
8.521600E-01
Normal-vs-Stage3
5.790000E-01
Normal-vs-Stage4
9.185000E-01
Stage1-vs-Stage2
6.557900E-02
Stage1-vs-Stage3
1.750240E-01
Stage1-vs-Stage4
2.749800E-01
Stage2-vs-Stage3
2.682000E-01
Stage2-vs-Stage4
7.567200E-01
Stage3-vs-Stage4
5.436400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.167800E-01
Normal-vs-AfricanAmerican
1.631370E-01
Normal-vs-Asian
4.369000E-01
Caucasian-vs-AfricanAmerican
1.335890E-02
Caucasian-vs-Asian
1.714950E-01
AfricanAmerican-vs-Asian
6.822400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.010200E-01
Normal-vs-Female
8.602400E-01
Male-vs-Female
8.175800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.728200E-01
Normal-vs-Age(41-60Yrs)
7.848000E-01
Normal-vs-Age(61-80Yrs)
8.904600E-01
Normal-vs-Age(81-100Yrs)
4.615200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.453200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.453200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.268600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.759400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.151800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.495810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.623000E-01
Normal-vs-Daily Drinker
6.661400E-01
Normal-vs-Weekly Drinker
6.188800E-01
Normal-vs-Occasional Drinker
6.654400E-01
Normal-vs-Social Drinker
5.865800E-01
Non Drinker-vs-Daily Drinker
2.566600E-01
Non Drinker-vs-Weekly Drinker
6.735000E-01
Non Drinker-vs-Occasional Drinker
8.612000E-01
Non Drinker-vs-Social Drinker
4.767400E-01
Daily Drinker-vs-Weekly Drinker
9.673700E-02
Daily Drinker-vs-Occasional Drinker
1.064430E-01
Daily Drinker-vs-Social Drinker
7.034000E-02
Weekly Drinker-vs-Occasional Drinker
6.926000E-01
Weekly Drinker-vs-Social Drinker
7.621400E-01
Occasional Drinker-vs-Social Drinker
5.128400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.211800E-01
Normal-vs-Grade 2
1.461600E-01
Normal-vs-Grade 3
1.303550E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.903200E-01
Grade 1-vs-Grade 3
7.928600E-01
Grade 1-vs-Grade 4
3.211800E-01
Grade 2-vs-Grade 3
7.650600E-01
Grade 2-vs-Grade 4
1.461600E-01
Grade 3-vs-Grade 4
1.303550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.954200E-01
Normal-vs-NonDiabetic
8.065600E-01
Diabetic-vs-NonDiabetic
2.484800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.484400E-01
Normal-vs-NoPancreatitis
9.260800E-01
Pancreatitis-vs-NoPancreatitis
1.333190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.216400E-01
Normal-vs-N1
9.834800E-01
N0-vs-N1
1.224070E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.283200E-01
Normal-vs-TP53-NonMutant
6.647800E-01
TP53-Mutant-vs-TP53-NonMutant
6.617400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
